Market Place
Sourcing Support
Vectura Fertin Pharma Announces Sale Agreement To Molex,Philip Morris Subsidiary
17 Sep 2024 //
BUSINESSWIRE
Aurora Cannabis And Vectura Fertin Pharma Announce Collaboration
01 Aug 2024 //
PR NEWSWIRE
Vectura’s Inhalation Center of Excellence Granted Planning Permission
27 Sep 2022 //
CONTRACT PHARMA
Executive Changes at Vectura
31 Mar 2022 //
PRESS RELEASE
Vectura wins Mediscience’s Best Communication Award
17 Nov 2021 //
PRESS RELEASE
How Philip Morris deal may affect Vectura’s sales of lung therapies
09 Oct 2021 //
BUSINESSLIVE
Inhaler firm Vectura removed from conference over Philip Morris takeover
16 Sep 2021 //
THEGUARDIAN
Philip Morris clinches shareholder backing for inhaler maker Vectura
16 Sep 2021 //
SKY NEWS
Tobacco firm Philip Morris seals £1.1bn takeover of UK inhaler maker Vectura
15 Sep 2021 //
THE GUARDIAN
Marlboro cigarette maker Philip Morris confirms majority of inhaler firm
15 Sep 2021 //
SCOTSMAN
Our CDMO expertise in the spotlight
24 Aug 2021 //
PRESS RELEASE
Philip Morris nabs over 20% of Vectura`s shares
19 Aug 2021 //
ENDPTS
Philip Morris firms position in Vectura takeover bid
19 Aug 2021 //
FIERCEPHARMA
Vectura board says it will unanimously back a Philip Morris takeover
14 Aug 2021 //
ENDPTS
Asthma Pharma Board Backs Big Tobacco Bid for $1 Billion Buyout
13 Aug 2021 //
BIOSPACE
FDA seeks input on pre-Hatch-Waxman ‘PANDA’ applications
12 Aug 2021 //
RAPS
Carlyle Group axes auction by calling its $1.3B bid for Vectura `final`
12 Aug 2021 //
ENDPTS
Philip Morris bags another biotech as bidding war with Carlyle
09 Aug 2021 //
ENDPTS
UK business secretary looking into Philip Morris` proposed deal to acquire Vectura
16 Jul 2021 //
ENDPTS
Philip Morris to buy UK`s Vectura for $1.44 billion
10 Jul 2021 //
REUTERS
Vectura Says VR942 Asthma Treatment Phase-One Trials Meet Objective
05 Jul 2021 //
FIRSTWORDPHARMA
Vectura, Incannex Enter Preclinical Services Agreement
22 Jun 2021 //
CONTRACTPHARMA
Vectura Signs Pre-Clinical Development Agreement with Incannex
22 Jun 2021 //
BIOSPECTRUMASIA
Vectura Group: Management Buyout of Skyepharma Subsidiary Has Completed
10 Jun 2021 //
MARKETWATCH
UK pharma group Vectura agrees $1.4 bln takeover by Carlyle
27 May 2021 //
REUTERS
Vectura Group plc: 2020 Preliminary Results
18 Mar 2021 //
PRESS RELEASE
Vectura Announces Dry Powder Inhaler Capabilities Expansion at UK Facility
10 Mar 2021 //
PHARMTECH
Vectura Expands Dry Powder Inhaler Capabilities
09 Mar 2021 //
CONTRACTPHARMA
Vectura provides update on GSK litigation
29 Dec 2020 //
VECTURA
Vectura earns $11m milestone as Hikma receives US FDA approval for generic
17 Dec 2020 //
VECTURA
Vectura earns $11m milestone as Hikma receives US FDA approval for generic
17 Dec 2020 //
PRESS RELEASE
Vectura leans into new role as inhalation CDMO post-asthma flop with plant
15 Dec 2020 //
ENDPTS
Vectura to Incorporate HPAPI Capabilities into UK Facility
14 Dec 2020 //
PHARMTECH
Vectura signs agreement with Kinaset Therapeutics Inc. to support VR588
29 Nov 2020 //
CHEMICALSKNOWLEGEHUB
Vectura Group plc - 2020 Interim ResultsÂ
15 Sep 2020 //
GLOBENEWSWIRE
Vectura & Monash University partner to support development of inhaled oxytocin
14 Sep 2020 //
PRESS RELEASE
Aerami Therapeutics Signs a Global License Agreement with Vectura Group
08 Jun 2020 //
PRESS RELEASE
Vectura signs agreement with Aerami Therapeutics Inc.
08 Jun 2020 //
GLOBENEWSWIRE
Vectura expands business development team with three global appointments
03 Jun 2020 //
PRESS RELEASE
Gilead`s ex-investor relations chief takes CFO job at Sangamo
02 Nov 2019 //
ENDPTS
Vectura Group Appoints New CEO
01 Nov 2019 //
CONTRACTPHARMA
Vectura, Sandoz win ruling on inhaler packaging case against GSK
05 Oct 2019 //
REUTERS
Vectura wins patent litigation battle against GSK, awarded $89.7M
07 May 2019 //
PHARMA TIMES
UK`s Vectura wins patent infringement case against GlaxoSmithKline in U.S
07 May 2019 //
REUTERS
GSK escapes Advair hit for now as second generic bid fails
13 Mar 2018 //
REUTERS
GSK wins new reprieve as Hikma`s generic Advair delayed again
12 Mar 2018 //
REUTERS
GSK eyes $1.7B bid for respiratory partner Vectura: report
17 Jan 2018 //
FIERCE PHARMA
Hikma, Vectura in dispute with FDA over generic Advair
08 Nov 2017 //
REUTERS
Vectura asthma inhaler makes "positive" regulatory progress in Europe
05 Oct 2017 //
REUTERS
Dry powder development: Vectura’s BI alternative backed by Pulmatrix
20 Sep 2017 //
IN PHARMATECHNOLOGIST
Drugmaker Vectura warns of destocking hit, shares slide
07 Sep 2017 //
REUTERS
Vectura posts bigger first half loss on increased R&D costs
05 Sep 2017 //
PROACTIVEINVESTOR
Drugmaker Vectura`s first-half revenue 6 % on rising sales of inhaled products
05 Sep 2017 //
REUTERS
Vectura allows Dynavax access to smart inhalers
16 Aug 2017 //
PHARMA TIMES
Vectura links with Novartis for inhaled asthma/COPD generic
30 Jun 2017 //
PHARMA TIMES
Vectura signs deal with Novartis for generic U.S. lung therapy
29 Jun 2017 //
REUTERS
Setback for Vectura/Hikma’s Advair Diskus generic
12 May 2017 //
PHARMA TIMES
Vectura trial gets green light for smart nebuliser trial
26 Jan 2017 //
PHARMATIMES
Mundipharma Bags Rights to Vectura’s Novel Respiratory Therapy
05 Jan 2017 //
PHARMATIMES
